Missing/wrong data?
Log in to edit
BCL-2 hypermethylation is a potential biomarker of sensitivity to antimitotic chemotherapy in endocrine-resistant breast cancer
scientific article published on 16 July 2013
Author/s
author: Mark J. Cowley, Andrew Biankin, Julia Gee, Cristin Print, Susan Clark, Rachael A McCloy, Liz Caldon, David Gallego-Ortega
Work details
Publication date
July 16, 2013
-
-
Language
English
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.